Related Experiment Video
Updated: Aug 9, 2025

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
Published on: April 13, 2022
Structure-based pharmacophore modeling 1. Automated random pharmacophore model generation.
Gregory L Szwabowski1, Judith A Cole2, Daniel L Baker1
1Department of Chemistry, The University of Memphis, Memphis, TN, 38152, USA.
This study presents a new method for generating structure-based pharmacophore models for G protein-coupled receptors (GPCRs). The approach effectively aids virtual screening in drug discovery, especially for GPCRs with limited known ligands.
Area of Science:
- Computational chemistry
- Drug discovery
- Structural biology
Background:
- Pharmacophores are crucial for virtual screening in drug discovery.
- G protein-coupled receptors (GPCRs) are important drug targets.
- Structure-based pharmacophore models are gaining prominence due to increased GPCR structure availability.
Purpose of the Study:
- To develop a method for generating structure-based pharmacophore models for GPCRs.
- To enable ligand discovery for GPCRs with few known ligands.
Main Methods:
- Generated pharmacophore models within the active sites of 8 class A GPCR crystal structures.
- Utilized automated annotation of functional group fragments.
- Screened 5000 pharmacophores against active and decoy compounds for 30 class A GPCRs.
- Assessed performance using enrichment factor and goodness-of-hit metrics.
Main Results:
- Pharmacophore models achieved the theoretical maximum enrichment factor in 8 out of 8 resolved structures.
- Models also showed high performance in 7 out of 8 homology models.
- The method demonstrated utility in virtual screening for GPCRs.
Conclusions:
- The developed method is effective for generating structure-based pharmacophore models.
- This approach can significantly aid virtual screening efforts in GPCR ligand discovery.
- The method shows promise for targets with limited known ligands.
More Related Videos
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
05:08Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Mechanistic Models: Overview of Compartment Models
Drug Discovery: Overview
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...